I'm back-in at $21.00
It is, what it is.
Recent IMNM News
- Immunome to Present at 2024 Bank of America Healthcare Conference • Business Wire • 05/08/2024 12:00:00 PM
- Immunome Appoints Kinney Horn as Chief Business Officer • Business Wire • 05/02/2024 12:00:00 PM
- Immunome Appoints Sandra M. Swain to Board of Directors • Business Wire • 04/25/2024 12:26:00 PM
- Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting • Business Wire • 04/05/2024 12:00:00 PM
- Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets • Business Wire • 03/28/2024 08:02:00 PM
- Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala • Business Wire • 03/26/2024 12:00:00 PM
- Immunome to Participate in the Leerink Partners Global Biopharma Conference • Business Wire • 03/07/2024 01:00:00 PM
- Immunome to Participate in the TD Cowen 44th Annual Healthcare Conference • Business Wire • 03/01/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:10:50 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:07:36 AM
- Immunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors • Business Wire • 02/20/2024 01:15:00 PM
- Immunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares • Business Wire • 02/16/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:11:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2024 09:09:03 PM
- Immunome Announces Pricing of Public Offering of Common Stock • Business Wire • 02/14/2024 03:38:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/13/2024 09:36:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:10:43 PM
- Immunome Announces Proposed Public Offering of Common Stock • Business Wire • 02/13/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 07:10:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:05:29 PM
- Immunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference • Business Wire • 02/05/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/02/2024 09:04:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 01:53:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 01:50:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:27:21 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM